TrialInvestigational new drugs2025

Efficacy and safety of fruquintinib plus capecitabine as first-line treatment in patients with metastatic colorectal cancer ineligible for intravenous chemotherapy: a two-stage, single-armed, phase II study.

Xin Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.